California Cannabis Research Medical Group
WWW.CCRMG.ORG
 

HOME
PROJECTS
MEMBERS
JOURNAL
CONTACT

Society of Cannabis Clinicians

 

 

 

 

 


Minutes December 2002


MINUTES OF DECEMBER 13, 2002, CCRMG MEETING

Present: Dr. Tod Mikuriya, Dr. Stephen Ellis, Dr. Tom O’Connell, Fred Gardner, Dr. Jeff Hergenrather, Dale Schafer, Dr. Richard Hansen, Dr. George Fuller, Dr. Frank Lucido, Sally Light, JD.

Agenda:

1. Introductions
2. Approve agenda
3. Approve minutes of last meeting
4. Reports/Updates:
a. California Medical Board hearing(s)
i. Dr. Fry’s Case
ii. Dr. Mikuriya’s case
iii. Dr. Lucido’s case
iv. Dr. Eidelman’s case
v. Dr. Ellis’ case
vi. Dr. Bearman’s case
vii. Dr. Banister’s case
viii. Dr. Alcalay’s case
b. Other state and federal political updates
c. Common face sheet
d. Minimum practice standards
e. Oakland office space
f. Other
5. Future events
6. Other
7. Date of next member meeting
8. Adjourn
*****************************************************

1. Introductions - Round table introductions opened the meeting.

2. Approve agenda – So approved.

3. Approve minutes of last meeting. – So approved.

4. Reports/Updates:

Instead of following the agenda point-by-point, here ensued a lengthy general discussion about the politico-legal situation the doctors now face re: the California Medical Board (CMB) and various court proceedings.

Dale Schafer reported on Dr. Fry’s case: Tom Campbell interviewed her last July, and the interview was to be transcribed and sent to the CMB, but she has not heard anything yet. Her defense will be based on “blanket transactional immunity” under 215. Dale is also using discovery to obtain documents proving governmental conspiracy against the doctors since 1996.

There was general agreement that they should take the offense against the CMB as soon as possible. Also discussed were how 215 and federal law interact/conflict, and how governmental authorities are attempting to usurp the role of doctors and to discriminate against patients. Dale believes that he is in a good position to file for declaratory relief, but it would be a massive case requiring lots of funding and other resources – however, if it can be done, he sees that ultimately the truth will come forth and the governmental defendants will lose in a big way. There are only a few attorneys that could handle this kind of case, involving standards, due process & other constitutional issues. However, the CMB’s standard (stated after 215’s passage) is “puny” and non-binding and therefore very challengeable

Dr. Mikuriya stated that last year his attorney, Bill Simpich, filed on his behalf against the CMB, but there has been no movement yet. It’s possible that other doctors could become co-plaintiffs at some point. Dr. Mikuriya has asked Bill S. to draft a budget and timeline for the case, but as Bill has been too busy to do this, Dr. Mikuriya asked Dale to take on this task. Dale accepted and agreed that payment of $1,000 was acceptable for this work.

Dale is now facing an upcoming Grand Jury investigation, for which he received notice only 3 days after the November 2002 election. He believes this is in retribution for his running for office.

Fred Gardner reported that Dr. Frank Fisher’s case had a recent hearing and that the outcome was good. He does not have any more information than that.

Fred Gardner also reported on the Sept. 28, 2002, conference in Reno of the American Academy of Pain Management, where Dr. Frank Fisher gave a presentation. About 500 attended overall, but the event was poorly organized, so very few attended Dr. Fisher’s session on cannabis as an alternative approach to pain management.

Fred Gardner stated that in his opinion, Lockyer should “clean house” of the Lungren –era attorneys and other bad apples in his department similar to the way Hallinan did after he was elected D.A. So far, Lockyer has let go only one such attorney. Also, Dr. William Breall has recently joined the CMB, and Fred sees him as approachable on the MM issue. Fred is writing a forthcoming article which will be an expose on the CMB.

Common face sheet - Dr. Jeff Hergenrather presented a draft common face sheet he developed after the last CCRMG meeting, using input from other members. After general discussion, including the idea of including a statement about informing patients when information is sent to anyone, it was agreed that he will revise it (with help from everyone) for the next quarterly meeting when hopefully it will be passed.

5. Other - Dr. Mikuriya presented the Harvard Medical School’s “Physical Health Study” on using aspirin in medical conditions. The study’s 20th anniversary commemoration was held recently, and both he and Dr. Rich Hansen received commemorative neckties for having participated in the study. Dr. M. believes that CCRMG should do a similar long-term study on cannabis.

6. Next Meeting – It was agreed that the next CCRMG meeting will be at noon on March 14, 2003.

7. As time ran out for the meeting to cover the remainder of the agenda items, they will be covered at the next meeting. The meeting was adjourned.

*******************************************

Minutes prepared by Sally Light, CCRMG Administrator


 

 

O'Shaughnessy's
O'Shaughnessy's is the journal of the CCRMG. Our primary goals are the same as the stated goals of any reputable scientific publication: to bring out findings that are accurate, duplicable, and useful to the community at large. But in order to do this, we have to pursue parallel goals such as removing the impediments to clinical research created by Prohibition, and educating our colleagues, co-workers and patients as we educate ourselves about the medical uses of cannabis. Read O'Shaughnessy's Online
 
SCC
The Society of Cannabis Clinicians (SCC) was formed in the Autumn of 2004 by the member physicians of CCRMG to aid in the promulgation of voluntary standards for clinicians engaged in the recommendation and approval of cannabis under California law (HSC §11362.5).

As the collaborative effort continues to move closer to issueing guidelines, this site serves as a public venue for airing and discussing these guidelines.

Visit the SCC Site for more information.